Skip to main content
RecallsAboutBlog

Drug recalls

Drug recalls from FDA, newest first.
Filters · 1Sort Newest
Agency
Risk level
Date
Sold in

1 recall

Neogen Uniprim Powder for Horses

Neogen Uniprim Powder for Horses have a defective container closure.

FDA, Packaging defect

3 recalls

Glenmark Abiraterone Acetate Tablets

Abiraterone Acetate Tablets have a labeling issue.

Moderate risk, FDA, Labeling error

Ritedose Formoterol Fumarate Inhalation Solution

Formoterol Fumarate Inhalation Solution failed impurities and degradation specifications.

Moderate risk, FDA, Drug impurity

Safecor Health Metoclopramide Tablets

Manufacturer is recalling batches due to co-mingled tablet.

Moderate risk, FDA, Foreign object

2 recalls

Strides Pharma Cinacalcet Tablets

Cinacalcet Tablets failed dissolution specifications.

FDA, Drug dissolving problem

AvKARE Amitriptyline Hydrochloride Tablets

Amitriptyline Hydrochloride tablets failed dissolution specifications.

FDA, Drug dissolving problem

1 recall

Wedgewood Compounded Veterinary Medications

Compounded veterinary medications may be subpotent or superpotent, posing health risks including ineffective treatment or toxicity.

FDA

1 recall

Right Value Drug Stores Testosterone Cypionate

Testosterone Cypionate, 200 mg/mL, lacks sterility assurance.

Moderate risk, FDA, Sterility problem

2 recalls

American Regent BetaVet Betamethasone Injectable Suspension for Horses

BetaVet betamethasone injectable suspension has defective container seals.

FDA, Packaging defect

Pritam International Toothpastes

Pritam International Toothpastes have CGMP deviations.

Moderate risk, FDA, Manufacturing problem

5 recalls

Ascend Laboratories Amlodipine and Olmesartan Medoxomil Tablets

Amlodipine and Olmesartan Medoxomil Tablets are out of specification due to dissolution.

Moderate risk, FDA, Drug dissolving problem

Shenzhen Techdow Pharmaceutical Heparin Sodium Injection

Heparin Sodium Injection lacks assurance of sterility.

Moderate risk, FDA, Sterility problem

Mylan Telmisartan and Amlodipine Tablets

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications.

Low risk, FDA, Wrong drug strength

Hikma Abirtega (Abiraterone Acetate) Tablets

Abirtega (abiraterone acetate) USP tablets failed weight uniformity specifications.

Moderate risk, FDA, Quality testing problem

Pfizer Levoxyl Levothyroxine Sodium Tablets

Levoxyl tablets are subpotent, confirmed by out-of-specification assay during stability testing.

Moderate risk, FDA, Wrong drug strength

1 recall

American Health Packaging Metoclopramide Tablets

Metoclopramide Tablets may contain foreign tablets or capsules.

Moderate risk, FDA, Foreign object

4 recalls

Par Pharmaceutical Argatroban Injection

Argatroban Injection may contain particulate matter that can cause life-threatening health consequences.

FDA, Foreign object

Zydus Hydrocortisone Sodium Succinate for Injection

Hydrocortisone Sodium Succinate for Injection failed impurities and degradation specifications.

Moderate risk, FDA, Drug impurity

Teva Metoclopramide Tablets

Metoclopramide Tablets, USP, 5 mg may contain foreign tablets or capsules.

Moderate risk, FDA, Foreign object

Houston Rx Sermorelin and Tirzepatide/Niacinamide Injections

Sermorelin sterile injectable solution lacks process control, and Tirzepatide/Niacinamide injection lacks assurance of sterility.

Moderate risk, FDA, Sterility problem

4 recalls

Par Brevital Sodium Methohexital Sodium

Brevital Sodium contains particulate matter that can cause life-threatening health consequences.

FDA, Foreign object

Sun Pharmaceutical Industries Tretinoin Cream

Tretinoin Cream USP, 0.05% failed impurities and degradation specifications.

Low risk, FDA, Drug impurity

Apothecary Pharma NAD+ and Tirzepatide Injections

Tirzepatide Injection lacks assurance of sterility.

Moderate risk, FDA, Sterility problem

Carolina Infusion Tirzepatide, Semaglutide and Tri-Mix Injectables

Carolina Infusion Tirzepatide, Semaglutide and Tri-Mix Injectables lack assurance of sterility.

Moderate risk, FDA, Sterility problem

1 recall

Cronus Pharma AnaSed Equine Injection

AnaSed Equine Injection may be discolored.

Moderate risk, FDA, Quality problem

2 recalls

Preferred Pharmaceuticals Lidocaine Ointment

Lidocaine Ointment USP, 5% failed content uniformity specifications.

Moderate risk, FDA, Quality testing problem

Cipla USA Fosfomycin Tromethamine Granules for Oral Solution

Fosfomycin Tromethamine Granules for Oral Solution failed impurities and degradation specifications.

Moderate risk, FDA, Drug impurity

1 recall

K.C. Pharmaceuticals Eye Drops

Artificial Tears Sterile Lubricant Eye Drops lack assurance of sterility.

Moderate risk, FDA, Sterility problem

5 recalls

Greenwich Rx Glutathione Injection

Glutathione injection may have elevated endotoxin levels, which could cause fevers, hypotension, inflammatory reactions, anaphylactic shock and death.

High risk, FDA, Sterility problem

PHP Animal Health Pet Drops Lubricant Eye Drops

PHP Animal Health Pet Drops Lubricant Eye Drops lack assurance of sterility.

Moderate risk, FDA, Sterility problem

Amazon Extra Strength Acetaminophen Caplets

Acetaminophen Extra Strength caplets have discolored tablets, which may indicate a problem.

FDA, Quality problem

Glenmark Pharmaceuticals Clindamycin Phosphate Foam, 1%

Clindamycin Phosphate Foam, 1% may leak from a defective container.

Moderate risk, FDA, Packaging defect

Omni Gold Anti-Marks Cream Extra Brightening and Orbi 20

Skin lightening products are contaminated with mercury.

High risk, FDA, Quality testing problem

2 recalls

Apotex Paroxetine Extended-Release Tablets

Paroxetine Extended-Release Tablets failed dissolution specifications.

Moderate risk, FDA, Drug dissolving problem

Endo USA Buprenorphine Hydrochloride Injection

Buprenorphine Hydrochloride Injection can crystallize.

Moderate risk, FDA, Quality problem

2 recalls

Zoladex (Goserelin) Implant

Zoladex (goserelin) implant was exposed to non-temperature-controlled conditions for 25.5 hours.

Moderate risk, FDA, Processing problem

Amneal Pharmaceuticals Estradiol Gel

Estradiol Gel packets may be empty or partially full.

Moderate risk, FDA, Packaging defect

2 recalls

Ajanta Pharma Ranolazine Extended-Release Tablets

Ranolazine Extended-Release Tablets fail dissolution specifications.

Moderate risk, FDA, Drug dissolving problem

Saving Sight Cornea

Corneas, recovered from donors whose donor eligibility was not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.

Low risk, FDA, Blood donor screening

1 recall

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops

Clear Eyes Redness Relief eye drops lack assurance of sterility.

Moderate risk, FDA, Sterility problem

4 recalls

Macleods Olanzapine Tablets

Olanzapine Tablets, USP 5 mg, failed impurities and degradation specifications.

Low risk, FDA, Drug impurity

Amneal Exenatide Injection

Exenatide Injection prefilled pens may contain no medication due to a defective delivery system.

Moderate risk, FDA, Device defect

The Blood Connection Red Blood Cells, Leukocytes Reduced

Red Blood Cells, Leukocytes Reduced were collected from a donor taking Proscar.

Moderate risk, FDA, Blood donor screening

The Blood Connection Red Blood Cells, Leukocytes Reduced

Red Blood Cells, Leukocytes Reduced were collected from a donor who had taken Accutane.

Moderate risk, FDA, Blood donor screening

2 recalls

Niwali Tejocote Capsules and Niwali Tejocote Pieces

Niwali Tejocote Capsules and Pieces contain yellow oleander, which can cause severe or fatal health effects.

FDA

Sterling Pharmaceutical Services Lubricant Eye Drops and Ointments

AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% lacks assurance of sterility.

Moderate risk, FDA, Sterility problem

1 recall

Endo Dexmedetomidine HCl in 0.9% Sodium Chloride Injection

Dexmedetomidine HCL in 0.9% Sodium Chloride Injection contains particulate matter that can cause life-threatening health consequences.

High risk, FDA, Foreign object

2 recalls

Hospira Dopamine HCl Injection

Dopamine HCl injection lacks assurance of sterility.

Moderate risk, FDA, Sterility problem

Dechra Veterinary Products Puralube Vet Ointment

Puralube Vet Ointment has cGMP deviations.

Moderate risk, FDA, Manufacturing problem

1 recall

Inventia Healthcare Chlorthalidone Tablets

Chlorthalidone Tablets failed dissolution specifications.

Moderate risk, FDA, Drug dissolving problem